A change in the initiation of donanemab dosing, shifting one vial of donanemab from the first infusion to the third infusion, lowered ARIA-E to 14% compared to 24% in patients receiving the standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback